Response to letter regarding article, "Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms".
Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, and Saint John, New Brunswick, Canada.
Shirya
S
Rashid
Center of Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR.
Hagai
H
Tavori
Department of Biostatistics, Faculty of Medicine, University of Toronto and Cancer Care, Toronto, ON, Canada.
Patrick E
PE
Brown
Department of Medicine, Section of Cardiovascular Disease Prevention, Vanderbilt University, Nashville, TN.
MacRae F
MF
Linton
Department of Medicine, Section of Cardiovascular Disease Prevention, Vanderbilt University, Nashville, TN.
Jane
J
He
Center of Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR.
Ilaria
I
Giunzioni
Center of Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR.
Sergio
S
Fazio
D000818:Animals; D001055:Apolipoproteins B / Q000378:metabolism*; D020895:Enterocytes / Q000378:metabolism*; D006801:Humans; D015228:Hypertriglyceridemia / Q000378:metabolism*; D043484:Proprotein Convertases / Q000378:metabolism*; D011973:Receptors, LDL / Q000378:metabolism*; D012697:Serine Endopeptidases / Q000378:metabolism*; D014280:Triglycerides / Q000378:metabolism*
D001055:Apolipoproteins B; D011973:Receptors, LDL; D014280:Triglycerides; D043484:Proprotein Convertases; D012697:Serine Endopeptidases